
Hormel Foods Corporation is rated a Buy due to its strong financial health, attractive 5.45% dividend yield, and flexible protein-focused product portfolio. The company projects FY26 net sales between $12.2 and $12.5 billion, with 1-4% organic growth and adjusted EPS of $1.43 to $1.51. Reduced capital expenditures are expected to improve free cash flow. While facing competitive pressures from private labels and macroeconomic challenges like inflation and consumer spending shifts, Hormel's expansion in international markets and foodservice sectors offers resilience. A discounted cash flow analysis suggests the stock is undervalued, providing a margin of safety for investors.